Propiedad y actividad de insiders de Neumora Therapeutics, Inc. Common Stock (NMRA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.77 |
| Capitalización | $143M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-20 | Aurora Daljit Singh | A-Award | 200,000 | $304K |
| 2026-08-20 | Aurora Daljit Singh | M-Exempt | 67,741 | $49K |
| 2026-08-20 | Aurora Daljit Singh | M-Exempt | 21,685 | $16K |
| 2026-08-20 | Aurora Daljit Singh | M-Exempt | 67,741 | $49K |
| 2026-08-21 | Aurora Daljit Singh | M-Exempt | 21,055 | $15K |
| 2026-08-21 | Aurora Daljit Singh | M-Exempt | 20,553 | $15K |
| 2026-08-21 | Aurora Daljit Singh | M-Exempt | 20,553 | $15K |
| 2026-08-20 | Aurora Daljit Singh | M-Exempt | 45,026 | $32K |
| 2026-08-20 | Aurora Daljit Singh | S-Sale | 67,741 | $103K |
| 2026-08-21 | Aurora Daljit Singh | S-Sale | 20,553 | $33K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | 0 | $192.0M | $409.2M | $240.9M | $374.0M | $142.1M | $182.5M |
| Inversiones a Corto | 0 | 0 | 0 | $130.9M | $79.9M | $165.4M | 0 |
| Cuentas por Cobrar | 0 | $148000 | $200000 | $919000 | $939000 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | 0 | $193.8M | $415.6M | $388.0M | $478.3M | $314.1M | $190.5M |
| Inmovilizado Material | 0 | $3.9M | $4.0M | $10.6M | $6.9M | $2.9M | $457000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | 0 | $197.9M | $429.3M | $426.2M | $496.2M | $317.0M | $191.0M |
| Cuentas por Pagar | 0 | $2.4M | $1.6M | $7.1M | $337000 | $3.3M | $3.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $284000 |
| Pasivos Corrientes | $21000 | $9.4M | $23.3M | $23.7M | $25.1M | $29.9M | $32.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $193000 |
| Pasivos Totales | $21000 | $292.3M | $754.5M | $873.1M | $27.1M | $29.9M | $87.2M |
| Reservas | -$21000 | -$99.3M | -$336.6M | -$467.5M | -$703.4M | -$947.2M | -$1.18B |
| Patrimonio Neto | -$21000 | -$94.4M | -$325.2M | -$446.9M | $469.1M | $287.1M | $103.9M |
| Deuda Total | 0 | $2.0M | $2.1M | $8.4M | $5.2M | $1.9M | $477000 |
| Deuda Neta | 0 | -$189.9M | -$407.2M | -$363.4M | -$448.8M | -$305.7M | -$182.1M |
| Capital Circulante | -$21000 | $184.5M | $392.3M | $364.3M | $453.2M | $284.2M | $158.1M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 4.50 |
Rentabilidad
| Rentabilidad sobre capital | -242.28% |
| Rentabilidad sobre capital invertido | -216.05% |
| Rentabilidad sobre activos | -169.86% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ADCT · ALMS · AUTL · BCYC · FDMT · FULC · LXRX
Explorar sector: Healthcare · Biotechnology
Más secciones de NMRA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones